2型糖尿病与心脏动患者的凝血活动增加有关:基于D-Dimer的分析
Paul Gabriel Ciubotaru1, Amit Kohli2, Nilima Rajpal Kundnani3,4
1Department V, Internal Medicine I-Discipline of Medical Semiology I, Center of Advanced Research in Cardiology and Hemostasology, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.
Biomedicines
|February 27, 2026
概括
在心房患者的2型糖尿病 (T2DM) 与较高的D-二次体水平有关,这表明凝血增加. 这表明糖尿病相关的高凝血性AF表型,独立于中风风险因素.
科学领域:
- 心脏病学 心脏病学
- 内分泌学 在内分泌学.
- 血液学 血液学 血液学
背景情况:
- 心房动 (AF) 增加了中风的风险,原因是原血栓状况.
- 2型糖尿病 (T2DM) 是AF患者常见的并发症,独立增加血栓栓塞的风险.
- 在AF患者中,T2DM对D-二次元水平的影响需要进一步的现实世界表征.
研究的目的:
- 调查T2DM和非膜AF患者的血D-二次数水平之间的独立关联.
- 在有或没有T2DM的AF患者中分析不同CHA2DS2-VASc风险类别的D-二聚合物水平.
- 评估T2DM在加剧AF中的前血栓状况中的作用.
主要方法:
- 对300名非膜性AF患者进行了回顾性观察性研究.
- 分为两组:有150名T2DM患者和150名无糖尿病患者.
- 多变量回归模型根据临床因素,功能和抗凝状态进行调整.
主要成果:
- 患有T2DM的患者具有显著更高的D-二元水平 (中位数为0.94比0.63微克/毫升FEU,p<0.001).
- T2DM独立地与D-二次体水平升高和超过值 (0.5和1.0微克/毫升FEU) 的几率增加有关.
- 在T2DM患者中,较高的D-二聚合物度在所有CHA2DS2-VASc风险类别中一致.
结论:
- 在AF患者中,T2DM独立地与增加的凝血活性有关,由较高的D-二次体水平证明.
- 这些发现支持一个独特的"与糖尿病相关的高凝血性AF表型".
- 凝血生物标志物,如D-二次体,可能会在患有T2DM的AF患者中完善风险分层.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.1K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.1K
Diabetes Mellitus: Type 2 and Gestational
5.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.2K
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
2.6K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.6K
Diabetes: Symptoms, Diagnosis, and Complications
2.5K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.5K
Coronary Artery Disease I: Introduction
1.3K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.3K
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
399
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
399


